Clinical Trial Update: Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of infliximab for colitis induced by immune checkpoint inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colitis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Odense University Hospital | Conditions: Colitis | Phase 3 | Status: RECRUITING